Anila Yasmeen

Cornell University — United States

Immunology and Microbiology · Life Sciences

28h-index4.6kcitations59works13.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(45), Monoclonal and Polyclonal Antibodies Research(30), Immune Cell Function and Interaction(13), HIV/AIDS drug development and treatment(10), Bacteriophages and microbial interactions(10)

Publications59 total

A modification to heptad repeat 1 of gp41 improves yield and/or quality of soluble pre-fusion HIV-1 envelope glycoprotein trimers
Journal of Virology·2025· 1 citedOpen Access
Germline-targeting HIV Envelope SOSIP immunization more frequently elicits broadly-neutralizing antibody precursor responses in infant compared to juvenile rhesus macaques
2025Open Access
Precise targeting of HIV broadly neutralizing antibody precursors in humans
Science·2025· 22 citedOpen Access
Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding site
Science Immunology·2024· 27 citedOpen Access
Immunization with germ line–targeting SOSIP trimers elicits broadly neutralizing antibody precursors in infant macaques
Science Immunology·2024· 15 citedOpen Access
Germline-targeting SOSIP trimer immunization elicits precursor CD4 binding-site targeting broadly neutralizing antibodies in infant macaques
2023· 2 citedOpen Access
Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization
PLoS Pathogens·2023· 9 citedOpen Access
Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization
2023· 2 citedOpen Access
Conformational antigenic heterogeneity as a cause of the persistent fraction in HIV-1 neutralization
Retrovirology·2023· 8 citedOpen Access
Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions
Cell Reports Medicine·2023· 43 citedOpen Access
Conformational antigenic heterogeneity as a cause of the persistent fraction in HIV-1 neutralization
Research Square (Research Square)·2023· 2 citedOpen Access
HIV-1 Germline-Targeting Vaccine Regimen Selects for Rare Immunoglobulin Insertions and Deletions Typical of VRC01-Class Antibodies
SSRN Electronic Journal·2022Open Access
Antibodies from Rabbits Immunized with HIV-1 Clade B SOSIP Trimers Can Neutralize Multiple Clade B Viruses by Destabilizing the Envelope Glycoprotein
Journal of Virology·2021· 11 citedOpen Access
Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in Saliva
Pathogens and Immunity·2021· 130 citedOpen Access
Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike
Cell Reports·2021· 61 citedOpen Access
Antibody responses to SARS-CoV-2 mRNA vaccines are detectable in saliva
2021· 34 citedOpen Access
Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
npj Vaccines·2021· 48 citedOpen Access
Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
2020· 6 citedOpen Access
Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers
Journal of Virology·2020· 19 citedOpen Access
Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens
PLoS Pathogens·2020· 73 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Per Johan Klasse(41), John P. Moore(41), Andrew B. Ward(37), Rogier W. Sanders(36), Gabriel Ozorowski(24), Albert Cupo(21), Ian A. Wilson(21), Max Crispin(18), Thomas J. Ketas(14), Ronald Derking(12), Marit J. van Gils(12), Steven W. de Taeye(12), David C. Montefiori(12), Rajesh P. Ringe(11), Joel D. Allen(11), Jean‐Philippe Julien(10), Jonathan L. Torres(10), Aleksandar Antanasijevic(10), Celia C. LaBranche(9), Philip J. M. Brouwer(9)